Considering the clinical data linking high NID2 expression with poor pancreatic cancer patient outcomes, we aimed to assess the functional role of NID2 using cancer cells and CAFs derived from the KPC mouse model (28, 36). This evidence concerns the gene NID2 and familial pancreatic carcinoma.